NO331057B1 - Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. - Google Patents
Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi.Info
- Publication number
- NO331057B1 NO331057B1 NO20101142A NO20101142A NO331057B1 NO 331057 B1 NO331057 B1 NO 331057B1 NO 20101142 A NO20101142 A NO 20101142A NO 20101142 A NO20101142 A NO 20101142A NO 331057 B1 NO331057 B1 NO 331057B1
- Authority
- NO
- Norway
- Prior art keywords
- combination preparation
- hypercholesterolemia
- treatment
- hyperlipidemia
- combination
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Alternative & Traditional Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Obesity (AREA)
- Diabetes (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Det er beskrevet et kombinasjonspreparat til behandling av hyperlipiemi og hyperkolesterolemi omfattende pyrroziildine alkaloider og fortrinnsvis hele, deler av og/eller et uttrekk eller ekstrakt av en plante av familien Asteraceae og fortrinnsvis Gynura diverticata DC i kombinasjon med et eller flere andre lipid- og/eller kolesterolnedsettende midler. Kombinasjonspreparatet oppviser en forbedret effekt i forhold til andre syntetiske kolesterolnedsettende medikamenter.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20101142A NO331057B1 (no) | 2010-08-12 | 2010-08-12 | Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. |
PCT/NO2011/000222 WO2012021068A1 (en) | 2010-08-12 | 2011-08-10 | Composition for treating hyperlipidemia |
EP11751960.3A EP2603211B1 (en) | 2010-08-12 | 2011-08-10 | Composition for treating hyperlipidemia |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
NO20101142A NO331057B1 (no) | 2010-08-12 | 2010-08-12 | Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20101142A1 NO20101142A1 (no) | 2011-09-26 |
NO331057B1 true NO331057B1 (no) | 2011-09-26 |
Family
ID=44545860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20101142A NO331057B1 (no) | 2010-08-12 | 2010-08-12 | Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2603211B1 (no) |
NO (1) | NO331057B1 (no) |
WO (1) | WO2012021068A1 (no) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102697826B (zh) * | 2012-06-18 | 2013-07-31 | 江苏省中国科学院植物研究所 | 一种白子菜蛋白提取物及其制备方法与应用 |
CN103230444B (zh) * | 2013-05-15 | 2014-03-19 | 李伟权 | 一种降脂护肝中药组合物及其制备方法和应用 |
TWI558403B (zh) * | 2013-06-04 | 2016-11-21 | 中央研究院 | 富含半乳糖脂之植物萃取物及其用途 |
CN105017438B (zh) * | 2015-07-13 | 2018-10-30 | 青岛海洋生物医药研究院股份有限公司 | 一种白背三七多糖及其在制备用于免疫调节和抗肿瘤的药物和功能食品中的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN100475232C (zh) * | 2006-07-17 | 2009-04-08 | 浙江杭州鑫富药业股份有限公司 | 一种治疗糖尿病的口服药物及其用途 |
CN101278957A (zh) | 2007-04-03 | 2008-10-08 | 郑乐建 | 白背三七提取物在于抗癌药物中的通途 |
-
2010
- 2010-08-12 NO NO20101142A patent/NO331057B1/no not_active IP Right Cessation
-
2011
- 2011-08-10 WO PCT/NO2011/000222 patent/WO2012021068A1/en active Application Filing
- 2011-08-10 EP EP11751960.3A patent/EP2603211B1/en not_active Not-in-force
Also Published As
Publication number | Publication date |
---|---|
NO20101142A1 (no) | 2011-09-26 |
WO2012021068A1 (en) | 2012-02-16 |
EP2603211A1 (en) | 2013-06-19 |
EP2603211B1 (en) | 2016-09-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA110054C2 (uk) | Розгалужені похідні 3-фенілпропіонової кислоти і їх застосування | |
WO2014145958A3 (en) | Network-based microbial compositions and methods | |
CR20130001A (es) | Derivados de indolizina, su procedimiento de preparación y su aplicación en terapéutica | |
PH12014502744A1 (en) | A pharmaceutical composition containing nicotinic acid and/or nicotinamide and/or tryptophan for positively influencing the intestinal microbiota | |
ECSP11011340A (es) | Nuevos derivados de benzotiadiazepinas, su procedimiento de preparación y composiciones farmacéuticas que los contienen | |
BRPI1006480A2 (pt) | sistema configurado para ajustar o volume tidal da respiração de um indivíduo que respira sozinho e método para ajustar o volume tidal da respiração de um indivíduo que respira sozinho. | |
WO2012049307A3 (en) | Novel n-terminally modified insulin derivatives | |
WO2014101295A3 (zh) | 一种詹纳斯激酶(jaks)抑制活性的异恶唑衍生物 | |
WO2013117744A3 (en) | Methods of treating fibrosis | |
BR112016012489A2 (pt) | cápsula, método de preparação de uma cápsula contendo flavonoides totais de desmodium styracifolium, e uso da cápsula | |
MX2013007436A (es) | Uso de estabilizadores de glutamina. | |
NO331057B1 (no) | Kombinasjonspreparat til behandling av hyperlipidemi og hyperkolesterolemi. | |
GB201303868D0 (en) | Pharmaceutical composition and methods of treating and preventing the diseases caused by HIV or associated with HIV | |
WO2011025978A3 (en) | Methods of treatment using anti-oxidized ldl antibodies | |
EA201792143A1 (ru) | Лекарственная форма для продленного высвобождения действующих веществ | |
BR112012004714A2 (pt) | preparação combinada de um extrato de cladódios de opuntia ficus indica e um extrato de folhas de olea europeae, e composição | |
BR112014029436A2 (pt) | método de obtenção de extrato rico em rutina a partir de uma planta; e extrato rico em rutina de uncaria elliptica | |
BR112013013179A2 (pt) | polimorfos de nor-udca ou bis-nor-udca, seu uso e método de preparação, bem como composições farmacêuticas que os compreendem | |
FR2985667B1 (fr) | Composition verrou aqueuse comprenant de l'ethanol et un anticoagulant polysaccharidique | |
EP3006450A4 (en) | Modified endotoxic bacteria lipopolysaccharide (variants), combination of modified lipopolysaccharides (variants) and, containing same, a vaccine (variants) and a pharmaceutical composition (variants) | |
EA201291191A1 (ru) | Фармацевтическая композиция для местного применения, содержащая гепарин | |
MX2015012730A (es) | Composicion prebiotica y metodo de uso. | |
FI20105265A0 (fi) | Jäähdytin ja valmistusmenetelmä | |
BRPI0705252A2 (pt) | fitomedicamento obtido a partir de schinus terebinthifolius raddi | |
UA73592U (ru) | Применение экстракта травы герани крупнокорневищной как средства с противовоспалительной и обезболивающей активностью |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM1K | Lapsed by not paying the annual fees |